Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -204,100 | 1,452,800 | 897,200 | -110,800 | 2,737,600 |
| Depreciation Amortization | 1,567,300 | 1,155,400 | 782,500 | 386,900 | 1,496,600 |
| Income taxes - deferred | -787,900 | 151,700 | 295,100 | 128,800 | 439,500 |
| Accounts receivable | -357,000 | N/A | N/A | N/A | -709,400 |
| Accounts payable and accrued liabilities | 916,300 | N/A | N/A | N/A | 1,123,800 |
| Other Working Capital | 3,204,900 | -525,200 | -1,118,500 | -995,000 | -484,100 |
| Other Operating Activity | 1,276,100 | 1,637,400 | 1,134,700 | 930,000 | 247,000 |
| Operating Cash Flow | $5,615,600 | $3,872,100 | $1,991,000 | $339,900 | $4,851,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,462,800 | -653,600 | -205,900 | 879,000 | 314,600 |
| PPE Investments | -1,076,800 | -633,300 | -390,600 | -169,000 | -963,600 |
| Net Acquisitions | -882,100 | -882,100 | -882,100 | -882,100 | -45,000 |
| Purchase Of Investment | -4,611,600 | -3,739,600 | -2,358,800 | -945,900 | -4,346,000 |
| Sale Of Investment | 2,586,000 | 1,686,900 | 1,107,600 | 528,000 | 2,086,000 |
| Other Investing Activity | -1,261,900 | -1,214,800 | -948,700 | -839,600 | -185,100 |
| Investing Cash Flow | $-3,783,600 | $-5,436,500 | $-3,678,500 | $-1,429,600 | $-3,139,100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,397,500 | 1,226,800 | 125,700 | 497,500 | 1,293,200 |
| Debt Issued | 2,232,000 | 2,232,000 | 2,232,000 | N/A | 1,206,600 |
| Debt Repayment | -630,600 | -630,600 | -630,500 | -630,200 | -200 |
| Common Stock Repurchased | -299,800 | -199,900 | -199,900 | N/A | -600,100 |
| Dividend Paid | -2,192,100 | -1,643,800 | -1,096,100 | -547,400 | -2,158,500 |
| Other Financing Activity | -364,400 | -299,600 | -247,000 | -195,600 | -300,800 |
| Financing Cash Flow | $142,600 | $684,900 | $184,200 | $-875,700 | $-559,800 |
| Exchange Rate Effect | -20,500 | 21,700 | -8,900 | 200 | -236,400 |
| Beginning Cash Position | 4,582,100 | 4,582,100 | 4,582,100 | 4,582,100 | 3,666,400 |
| End Cash Position | 6,536,200 | 3,724,300 | 3,069,900 | 2,616,900 | 4,582,100 |
| Net Cash Flow | $1,954,100 | $-857,800 | $-1,512,200 | $-1,965,200 | $915,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,615,600 | 3,872,100 | 1,991,000 | 339,900 | 4,851,000 |
| Capital Expenditure | -1,076,800 | -633,300 | -390,600 | -169,000 | -1,037,000 |
| Free Cash Flow | 4,538,800 | 3,238,800 | 1,600,400 | 170,900 | 3,814,000 |